These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38831886)

  • 1. Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria.
    Khan FM; Rasheed F; Yang Y; Liu B; Zhang R
    Front Pharmacol; 2024; 15():1385261. PubMed ID: 38831886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria.
    Gontijo MTP; Jorge GP; Brocchi M
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin.
    Park W; Park M; Chun J; Hwang J; Kim S; Choi N; Kim SM; Kim S; Jung S; Ko KS; Kweon DH
    Int J Antimicrob Agents; 2024 Aug; 64(2):107216. PubMed ID: 38795926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
    Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
    Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends.
    Lee C; Kim H; Ryu S
    Crit Rev Food Sci Nutr; 2023; 63(27):8919-8938. PubMed ID: 35400249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant
    Islam MM; Kim D; Kim K; Park SJ; Akter S; Kim J; Bang S; Kim S; Kim J; Lee JC; Hong CW; Shin M
    Front Microbiol; 2022; 13():988522. PubMed ID: 36225352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
    Liu H; Hu Z; Li M; Yang Y; Lu S; Rao X
    J Biomed Sci; 2023 Apr; 30(1):29. PubMed ID: 37101261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective.
    Khan FM; Chen JH; Zhang R; Liu B
    Front Microbiol; 2023; 14():1259210. PubMed ID: 37869651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Advantages and Challenges of Using Endolysins in a Clinical Setting.
    Murray E; Draper LA; Ross RP; Hill C
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections.
    Vasina DV; Antonova NP; Gushchin VA; Aleshkin AV; Fursov MV; Fursova AD; Gancheva PG; Grigoriev IV; Grinkevich P; Kondratev AV; Kostarnoy AV; Lendel AM; Makarov VV; Nikiforova MA; Pochtovyi AA; Prudnikova T; Remizov TA; Shevlyagina NV; Siniavin AE; Smirnova NS; Terechov AA; Tkachuk AP; Usachev EV; Vorobev AM; Yakimakha VS; Yudin SM; Zackharova AA; Zhukhovitsky VG; Logunov DY; Gintsburg AL
    J Biomed Sci; 2024 Jul; 31(1):75. PubMed ID: 39044206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of sensitizer peptide-fused endolysin Lys1S-L9P acting against multidrug-resistant gram-negative bacteria.
    Son SM; Kim J; Ryu S
    Front Microbiol; 2023; 14():1296796. PubMed ID: 38075915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolysin, a Promising Solution against Antimicrobial Resistance.
    Rahman MU; Wang W; Sun Q; Shah JA; Li C; Sun Y; Li Y; Zhang B; Chen W; Wang S
    Antibiotics (Basel); 2021 Oct; 10(11):. PubMed ID: 34827215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria.
    Gonçalves T; Marques AT; Manageiro V; Tanoeiro L; Vital JS; Duarte A; Vítor JMB; Caniça M; Gaspar MM; Vale FF
    Int J Pharm; 2024 Feb; 651():123758. PubMed ID: 38160991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids.
    Yan G; Yang R; Fan K; Dong H; Gao C; Wang S; Yu L; Cheng Z; Lei L
    AMB Express; 2019 Jul; 9(1):106. PubMed ID: 31309363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.